Seminars in pediatric neurology
November 13, 2025 · via Europe PMC
Surgical management of Lennox-Gastaut syndrome: A focused update on resective surgery and corpus callosotomy.
Hagen CW, Keator CG.
AI summary — for doctors, generated from the abstract only
This review summarizes recent literature on resective epilepsy surgery and corpus callosotomy for Lennox-Gastaut syndrome, noting continued clinical hesitance toward surgical evaluation in this population despite epilepsy surgery remaining a viable treatment consideration.
What was studied
This is a focused review of the past five years of literature on non-neuromodulatory surgical approaches-specifically resective (curative and palliative) surgery and corpus callosotomy-for Lennox-Gastaut syndrome (LGS), building on a prior 2021 review, with attention to the secondary neural network involved in LGS and future surgical directions.
Key findings
- Epilepsy surgery is described as remaining a viable treatment consideration for developmental epileptic encephalopathies including LGS
- The review notes continued clinical hesitance toward pursuing surgical evaluation in these conditions
- Special attention is given in the recent literature to the secondary network involved in LGS and future directions in novel surgical techniques and potential biomarkers for LGS
Clinical relevance
The findings suggest that despite ongoing hesitance, resective surgery and corpus callosotomy remain important treatment options to consider for appropriately selected patients with Lennox-Gastaut syndrome, and that emerging understanding of LGS's underlying neural network involvement may eventually refine patient selection and surgical techniques. As a review, this synthesizes existing literature rather than presenting new surgical outcome statistics.
Who should care
Limitations
As a narrative review, it does not report original patient-level surgical outcome data, specific statistics, or a systematic search methodology in the available abstract text.
This review highlights persistent clinical hesitance toward epilepsy surgery for Lennox-Gastaut syndrome despite its continued viability as a treatment option, and points to emerging research on LGS's neural network involvement as a direction for refining future surgical approaches.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Epilepsy surgery remains a viable consideration for the treatment of developmental epileptic encephalopathies (DEEs), specifically Lennox Gastaut Syndrome (LGS). Previously, Keator (2021) reviewed the current literature on epilepsy surgery for LGS including resective and neuromodulating techniques. There continues to be a hesitance to pursuing surgical evaluation in DEEs. Herein, this review continues to explore the recent literature in regard to non-neuromodulating techniques focusing on resective (curative and palliative) and corpus callosotomies in patients with LGS. Specifically, the last five years of the current literature are reviewed in non-neuromodulatory surgical approaches for LGS. In the current literature, there is also special attention focusing on the secondary network involved in LGS as well as the future directions in novel surgical techniques and the identification of potential biomarkers for LGS.
DOI
10.1016/j.spen.2025.101235
PMID
41371869
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed